BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28459774)

  • 21. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery.
    Zareba P; Wu C; Agzarian J; Rodriguez D; Kearon C
    Br J Surg; 2014 Aug; 101(9):1053-62. PubMed ID: 24916118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.
    Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
    Ann Surg; 2018 Apr; 267(4):727-733. PubMed ID: 28475558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effectiveness and Safety of Direct Oral Anticoagulants Following Lower Limb Fracture Surgery: A Systematic Review and Meta-analysis.
    Wæver D; Lewis D; Saksø H; Borris LC; Tarrant S; Thorninger R
    J Orthop Trauma; 2021 Apr; 35(4):217-224. PubMed ID: 32956205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prospective Cohort Study of Symptomatic Venous Thromboembolic Events in Foot and Ankle Trauma: The Need for Stratification in Thromboprophylaxis?
    Blanco JA; Slater G; Mangwani J
    J Foot Ankle Surg; 2018; 57(3):484-488. PubMed ID: 29503135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprophylaxis for the Hip Fracture Patient: A Comparison of Warfarin and Low-Molecular-Weight Heparin.
    Trivedi NN; Sivasundaram L; Wang C; Kim CY; Buser Z; Wang JC; Ochenjele G
    J Orthop Trauma; 2019 May; 33(5):216-219. PubMed ID: 31008818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of venous thromboprophylaxis in isolated severe pelvic fracture: Effect on mortality and outcomes.
    Benjamin E; Aiolfi A; Recinos G; Inaba K; Demetriades D
    Injury; 2019 Mar; 50(3):697-702. PubMed ID: 30797543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis.
    Yang AD; Hewitt DB; Blay E; Kreutzer LJ; Quinn CM; Cradock KA; Prachand V; Bilimoria KY;
    Ann Surg; 2020 Jun; 271(6):1072-1079. PubMed ID: 30632990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
    Adam SS; McDuffie JR; Ortel TL; Williams JW
    Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK; Kirkilesis GI; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of venous thromboembolism chemoprophylaxis with major surgery of lower-extremity long bone fractures.
    Salottolo K; Carrick M; Nwafo N; Madayag R; Tanner A; Corrigan C; Banton K; Bar-Or D
    J Trauma Acute Care Surg; 2023 Jan; 94(1):169-176. PubMed ID: 35999663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Thromboembolism Chemoprophylaxis in Trauma and Emergency General Surgery Patients: A Systematic Review.
    Sanchez C; Nguyen J; Baroutjian A; Gill S; McKenney M; Elkbuli A
    J Trauma Nurs; 2021 Sep-Oct 01; 28(5):323-331. PubMed ID: 34491950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.
    Ageno W; Bosch J; Cucherat M; Eikelboom JW
    J Thromb Thrombolysis; 2016 Jul; 42(1):90-8. PubMed ID: 26497987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy.
    Schomburg J; Krishna S; Soubra A; Cotter K; Fan Y; Brown G; Konety B
    Urol Oncol; 2018 Feb; 36(2):77.e9-77.e13. PubMed ID: 29097086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.
    Fagarasanu A; Alotaibi GS; Hrimiuc R; Lee AY; Wu C
    Ann Surg Oncol; 2016 May; 23(5):1422-30. PubMed ID: 26887853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low to Moderate Risk Non-orthopedic Surgical Patients Do Not Benefit From VTE Chemoprophylaxis.
    Sutzko DC; Obi AT; Kamdar N; Karamkar M; Wakefield TW; Osborne NH; Henke PK
    Ann Surg; 2022 Dec; 276(6):e691-e697. PubMed ID: 33214487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.